Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Cell-surface Notch1 expression identifies a primitive phenotype within CD34+ CD38- haematopoietic cells.

Portillo V, Chadwick N, Lloyd R, Jackson D, Buckle AM.

Eur J Haematol. 2014 Jan;92(1):26-34. doi: 10.1111/ejh.12200. Epub 2013 Oct 29.

PMID:
24010734
[PubMed - indexed for MEDLINE]
2.

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.

Rappold I, Ziegler BL, Köhler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Bühring HJ.

Blood. 1997 Jul 1;90(1):111-25.

PMID:
9207445
[PubMed - indexed for MEDLINE]
Free Article
3.

Differences amid bone marrow and cord blood hematopoietic stem/progenitor cell division kinetics.

da Silva CL, Gonçalves R, Porada CD, Ascensão JL, Zanjani ED, Cabral JM, Almeida-Porada G.

J Cell Physiol. 2009 Jul;220(1):102-11. doi: 10.1002/jcp.21736.

PMID:
19277981
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.

da Silva CL, Gonçalves R, dos Santos F, Andrade PZ, Almeida-Porada G, Cabral JM.

J Tissue Eng Regen Med. 2010 Feb;4(2):149-58. doi: 10.1002/term.226.

PMID:
19937912
[PubMed - indexed for MEDLINE]
5.

Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.

Pierre-Louis O, Clay D, Brunet de la Grange P, Blazsek I, Desterke C, Guerton B, Blondeau C, Malfuson JV, Prat M, Bennaceur-Griscelli A, Lataillade JJ, Le Bousse-Kerdilès MC.

Stem Cells. 2009 Oct;27(10):2552-62. doi: 10.1002/stem.186.

PMID:
19650038
[PubMed - indexed for MEDLINE]
Free Article
6.

Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.

Wong WM, Sigvardsson M, Åstrand-Grundström I, Hogge D, Larsson J, Qian H, Ekblom M.

Stem Cells. 2013 Feb;31(2):360-71. doi: 10.1002/stem.1282.

PMID:
23165626
[PubMed - indexed for MEDLINE]
7.

CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.

Murray LJ, Bruno E, Uchida N, Hoffman R, Nayar R, Yeo EL, Schuh AC, Sutherland DR.

Exp Hematol. 1999 Aug;27(8):1282-94.

PMID:
10428505
[PubMed - indexed for MEDLINE]
8.

Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells.

Ziegler BL, Thoma SJ, Lamping CP, Valtieri M, Müller R, Samoggia P, Bühring HJ, Peschle C, Fliedner TM.

Cytometry. 1996 Sep 1;25(1):46-57.

PMID:
8875054
[PubMed - indexed for MEDLINE]
9.

Human cord blood long-term engrafting cells are CD34+ CD38-.

Ishikawa F, Livingston AG, Minamiguchi H, Wingard JR, Ogawa M.

Leukemia. 2003 May;17(5):960-4.

PMID:
12750710
[PubMed - indexed for MEDLINE]
10.

[A preliminary study on the culture of single hematopoietic stem cell].

Han YJ, Qi JY, Qiu LG.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Feb;34(1):19-24. Chinese.

PMID:
22737714
[PubMed - indexed for MEDLINE]
Free Article
12.

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.

Kawakami M, Kimura T, Kishimoto Y, Tatekawa T, Baba Y, Nishizaki T, Matsuzaki N, Taniguchi Y, Yoshihara S, Ikegame K, Shirakata T, Nishida S, Masuda T, Hosen N, Tsuboi A, Oji Y, Oka Y, Ogawa H, Sonoda Y, Sugiyama H, Kawase I, Soma T.

Leukemia. 2004 May;18(5):912-21.

PMID:
14999295
[PubMed - indexed for MEDLINE]
13.

T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells.

De Smedt M, Leclercq G, Vandekerckhove B, Kerre T, Taghon T, Plum J.

Haematologica. 2011 May;96(5):646-54. doi: 10.3324/haematol.2010.036343. Epub 2011 Feb 17.

PMID:
21330325
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A functional comparison of CD34 + CD38- cells in cord blood and bone marrow.

Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM.

Blood. 1995 Nov 15;86(10):3745-53.

PMID:
7579341
[PubMed - indexed for MEDLINE]
Free Article
15.

In vitro effects of stromal cells expressing different levels of Jagged-1 and Delta-1 on the growth of primitive and intermediate CD34(+) cell subsets from human cord blood.

Fernández-Sánchez V, Pelayo R, Flores-Guzmán P, Flores-Figueroa E, Villanueva-Toledo J, Garrido E, Ruiz-Sánchez E, Alvarez-Sanchez E, Mayani H.

Blood Cells Mol Dis. 2011 Dec 15;47(4):205-13. doi: 10.1016/j.bcmd.2011.08.003. Epub 2011 Sep 10.

PMID:
21911304
[PubMed - indexed for MEDLINE]
16.

Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells.

Davis BR, Yannariello-Brown J, Prokopishyn NL, Luo Z, Smith MR, Wang J, Carsrud ND, Brown DB.

Blood. 2000 Jan 15;95(2):437-44.

PMID:
10627447
[PubMed - indexed for MEDLINE]
Free Article
17.

[Karyotyping and immunophenotyping analyses of the CD34+ CD38- cells isolated from human umbilical cord blood].

Tian H, Zheng JE, Gong FL, Wang XB, Huang SA, Chen Z.

Zhonghua Xue Ye Xue Za Zhi. 2005 May;26(5):257-60. Chinese.

PMID:
15949281
[PubMed - indexed for MEDLINE]
18.
19.

Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells.

Rosler E, Brandt J, Chute J, Hoffman R.

Exp Hematol. 2000 Jul;28(7):841-52.

PMID:
10907646
[PubMed - indexed for MEDLINE]
20.

Selective in vitro expansion and efficient retroviral transduction of human CD34+ CD38- haematopoietic stem cells.

Ng YY, Bloem AC, van Kessel B, Lokhorst H, Logtenberg T, Staal FJ.

Br J Haematol. 2002 Apr;117(1):226-37.

PMID:
11918560
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk